Utama › Kanser Ginjal (Karsinoma Sel Renal) › Texas › Dallas
Kajian klinikal Kanser Ginjal (Karsinoma Sel Renal) di Dallas, TX
23 kajian untuk Kanser Ginjal (Karsinoma Sel Renal) sedang mencari peserta di lokasi dalam dan sekitar Dallas (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
Open-Label Phase 1/2 Study of NEO-811 in Subjects With Locally Advanced or Metastatic Non-Resectable Clear Cell Renal Cell Carcinoma
Mengambil pesertaFasa 1
- NEO-811 Dallas Site, Dallas
A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma
Mengambil pesertaFasa 1
- Texas Oncology, Dallas
- University of Texas Southwestern Medical Center, Dallas
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
Mengambil pesertaFasa 1
- Exelixis Clinical Site #89, Dallas
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
Mengambil pesertaFasa 2
- UT Southwestern Simmons Cancer Center - RedBird, Dallas
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
DESTINY-PANTUMOUR04
Mengambil pesertaKajian pemerhatian
- Research Site, Dallas
Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Mengambil pesertaFasa 1/2
- Baylor, Scott and White Research Institute, Dallas
Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial
Mengambil pesertaFasa 2
- Parkland Memorial Hospital, Dallas
- UT Southwestern Simmons Cancer Center - RedBird, Dallas
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
Mengambil pesertaFasa 1/2
- University of Texas Southwestern Medical Center - Simmons Cancer Center, Dallas
- University of Texas Southwestern Medical Center-William P. Clements Jr. University Hospital, Dallas
- University of Texas Southwestern Simmons Cancer Center - Redbird, Dallas
- dan 2 lagi
Neoadjuvant Lenvatinib and Pembrolizumab for IVC Tumor Thrombus
Mengambil pesertaFasa 2
- University of Texas Southwestern Medical Center, Dallas
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Mengambil pesertaKajian pemerhatian
- UT Southwestern Medical Center, Dallas
Safety and Preliminary Effectiveness of BNT317, an Investigational Therapy for Advanced Solid Tumors
Mengambil pesertaFasa 1/2
- Mary Crowley Cancer Research, Dallas
Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer
Mengambil pesertaFasa 3
- Parkland Memorial Hospital, Dallas
- UT Southwestern Simmons Cancer Center - RedBird, Dallas
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
Genetic Testing to Select Therapy for the Treatment of Advanced or Metastatic Kidney Cancer, OPTIC RCC Study
Mengambil pesertaFasa 2
- University of Texas, Southwestern Medical Center, Dallas
PET/MR for Characterization of Renal Masses (RMs)
Mengambil pesertaKajian pemerhatian
- University of Texas Southwestern Medical Center, Dallas
KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
Mengambil pesertaFasa 1
- UT Southwestern Simmons Cancer Center, Dallas
Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors
Mengambil pesertaFasa 1
- University of Texas Southwestern Medical Center /ID# 251974, Dallas
Phase 2 Study of Combination Tivozanib and Nivolumab in Advanced Non-Clear Cell Renal Cell Carcinoma
Mengambil pesertaFasa 2
- UT Southwestern Medical Center, Dallas
A Study of VET3-TGI in Patients With Solid Tumors
Mengambil pesertaFasa 1
- Mary Crowley Cancer Research, Dallas
An Investigation of Kidney and Urothelial Tumor Metabolism in Patients Undergoing Surgical Resection and/or Biopsy
Mengambil pesertaSukarelawan sihat dialu-alukan
- University of Texas Southwestern Medical Center, Dallas
[18F]PT2385 PET/CT in Patients With Renal Cell Carcinoma
Mengambil pesertaFasa 1
- UT Southwestern Medical Center, Dallas
Radiotherapy in Combination With Checkpoint Inhibition for Patients With Metastatic Kidney Cancer
Mengambil pesertaFasa 2
- University of Texas Southwestern Medical Center, Dallas
Sequential Treatment of Cabozantinib for Advanced Renal Cell Carcinoma (RCC)
Mengambil pesertaFasa 2
- UT Southwestern Medical Center, Dallas
Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial
Mengambil pesertaFasa 3
- UT Southwestern Simmons Cancer Center - RedBird, Dallas
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
Kajian Kanser Ginjal (Karsinoma Sel Renal) di bandar lain
- Houston, TX35 kajian
- New York City, NY27 kajian
- Nashville, TN23 kajian
- St. Louis, MO23 kajian
- Los Angeles, CA20 kajian
- Boston, MA16 kajian
- Baldwin Park, CA16 kajian
- Philadelphia, PA15 kajian
- Pittsburgh, PA15 kajian
- Queens, NY15 kajian
- Rochester, MN14 kajian
- Cleveland, OH14 kajian
Kajian lain di Dallas
- Kanser Payudara55 kajian
- Kanser Paru-paru Bukan Sel Kecil52 kajian
- Kanser Metastatik42 kajian
- Kegagalan Jantung42 kajian
- Kanser (semua jenis)37 kajian
- Kanser Prostat36 kajian
- Kanser Kolorektal33 kajian
- Obesiti30 kajian
- Kanser Ovari28 kajian
- Kanser Paru-paru27 kajian
- Kanser Pundi Kencing27 kajian
- Kanser Endometrium24 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.